{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:10:10Z","timestamp":1746677410732,"version":"3.40.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#301500\/2022-3"],"award-info":[{"award-number":["#301500\/2022-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The coexistence of dermatomyositis (DM)\/clinically amyopathic DM (CADM) and psoriasis has been infrequently documented in the literature. Consequently, this study aimed to analyze this entity from our tertiary center and review the relevant literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective observational cross-sectional study and case series included patients with DM\/CADM and psoriasis between 1998 and 2024. A literature review was also conducted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Nine of 331 patients with DM (<jats:italic>n<\/jats:italic>\u2009=\u2009265)\/CADM (<jats:italic>n<\/jats:italic>\u2009=\u200966) had psoriasis; six were female, and all were of white ethnicity. The median age at DM diagnosis was 38 years (range: 18\u201378), and at psoriasis diagnosis was 43 years (range: 18\u201381), with a median interval of four years between diagnoses. The follow-up revealed that six patients were discharged, two died, and one continued follow-up. The primary comorbidities included systemic arterial hypertension (<jats:italic>n<\/jats:italic>\u2009=\u20093) and diabetes mellitus (<jats:italic>n<\/jats:italic>\u2009=\u20093). Four patients presented with varicella zoster (<jats:italic>n<\/jats:italic>\u2009=\u20091) or pulmonary tuberculosis (<jats:italic>n<\/jats:italic>\u2009=\u20093). Regarding the literature review, 15 articles reported a total of 17 cases of overlapping DM\/CADM and psoriasis. However, variability was observed in the DM\/CADM diagnostic criteria. The mean age at DM diagnosis in the literature was 32.3 years (range: 2\u201359), whereas for psoriasis, it was 31 (7\u201363) years. Female patients were predominant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This investigation identified the coexistence of DMPs, with a median age of 38 years for DM and 43 years for psoriasis. The variability in the diagnostic criteria underscores the necessity for standardized approaches to enhance patient management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s42358-025-00454-7","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T13:37:22Z","timestamp":1746625042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patients with overlapping dermatomyositis and psoriasis: an experience from a tertiary center and review of the literature"],"prefix":"10.1186","volume":"65","author":[{"given":"Beatriz Westphalen","family":"Pomianoski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-4517","authenticated-orcid":false,"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"454_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/acr.24786","volume":"75","author":"VL Kronzer","year":"2023","unstructured":"Kronzer VL, Kimbrough BA, Crowson CS, Davis JM 3rd, Holmqvist M, Ernste FC. Incidence, prevalence, and mortality of dermatomyositis: a population-based cohort study. Arthritis Care Res (Hoboken). 2023;75:348\u201355. https:\/\/doi.org\/10.1002\/acr.24786.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"454_CR2","doi-asserted-by":"publisher","first-page":"16444","DOI":"10.1038\/s41598-023-43880-7","volume":"13","author":"M Osman","year":"2023","unstructured":"Osman M, Martins KJB, Wong KO, Vu K, Guigue A, Cohen Tervaert JW, et al. Incidence and prevalence, and medication use among adults living with dermatomyositis: an Alberta, Canada population-based cohort study. Sci Rep. 2023;13:16444. https:\/\/doi.org\/10.1038\/s41598-023-43880-7.","journal-title":"Sci Rep"},{"key":"454_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"20","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;20:362:971\u201382.","journal-title":"Lancet"},{"key":"454_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263\u201371.","journal-title":"Lancet"},{"key":"454_CR5","doi-asserted-by":"publisher","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20:1475. https:\/\/doi.org\/10.3390\/ijms20061475.","DOI":"10.3390\/ijms20061475"},{"key":"454_CR6","doi-asserted-by":"publisher","first-page":"1345646","DOI":"10.3389\/fimmu.2024.1345646","volume":"15","author":"D Chu","year":"2024","unstructured":"Chu D, Yang W, Niu J. Concurrence of dermatomyositis and psoriasis: a case report and literature review. Front Immunol. 2024;15:1345646. https:\/\/doi.org\/10.3389\/fimmu.2024.1345646.","journal-title":"Front Immunol"},{"key":"454_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.55563\/clinexprheumatol\/ki4jbt","volume":"42","author":"Z Xu","year":"2024","unstructured":"Xu Z, Xu B, Zhao B, Gao H, Ye S, Wu J. Treatment of refractory psoriasis with dermatomyositis using Upadacitinib. Clin Exp Rheumatol. 2024;42:458\u20139. https:\/\/doi.org\/10.55563\/clinexprheumatol\/ki4jbt.","journal-title":"Clin Exp Rheumatol"},{"key":"454_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jamadermatol.2021.6011","volume":"158","author":"DL Perna","year":"2022","unstructured":"Perna DL, Callen JP, Schadt CR. Association of treatment with Secukinumab with exacerbation of dermatomyositis in a patient with psoriasis. JAMA Dermatol. 2022;158:454\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2021.6011.","journal-title":"JAMA Dermatol"},{"key":"454_CR9","doi-asserted-by":"publisher","first-page":"232470962110577","DOI":"10.1177\/23247096211057702","volume":"9","author":"C Schreiber","year":"2021","unstructured":"Schreiber C, Khamlong M, Raza N, Huynh BQ. Overlap of psoriatic arthritis and dermatomyositis. J Investig Med High Impact Case Rep. 2021;9:23247096211057702. https:\/\/doi.org\/10.1177\/23247096211057702.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"454_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/ccr3.2219","volume":"7","author":"A Markovic","year":"2019","unstructured":"Markovic A, Schuster V, Simon JC, Kunz M. Erythematous scaling lesions of the face, dorsal fingers, elbows, and knees together with symmetrical muscle weakness in a child. Clin Case Rep. 2019;7:1347\u20139. https:\/\/doi.org\/10.1002\/ccr3.2219.","journal-title":"Clin Case Rep"},{"key":"454_CR11","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/jocd.12869","volume":"18","author":"Y Xing","year":"2019","unstructured":"Xing Y, Xie J, Jiang S, Upasana M, Song J. Co-existence of juvenile dermatomyositis and psoriasis vulgaris with fungal infection: A case report and literature review. J Cosmet Dermatol. 2019;18:1560\u20133. https:\/\/doi.org\/10.1111\/jocd.12869.","journal-title":"J Cosmet Dermatol"},{"key":"454_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/1756-185X.13084","volume":"20","author":"Y Kato","year":"2017","unstructured":"Kato Y, Yamamoto T. Development of psoriasis with relapse of dermatomyositis-associated interstitial lung disease. Int J Rheum Dis. 2017;20:660\u20131. https:\/\/doi.org\/10.1111\/1756-185X.13084.","journal-title":"Int J Rheum Dis"},{"key":"454_CR13","doi-asserted-by":"crossref","unstructured":"Inkeles MS, No D, Wu JJ. Clinical improvement of a patient with both amyopathic dermatomyositis and psoriasis following treatment with cyclosporine. Dermatol Online J. 2017;23:13030\/qt5qh0n741.","DOI":"10.5070\/D3238036019"},{"key":"454_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/RHU.0000000000000430","volume":"23","author":"CL Montoya","year":"2017","unstructured":"Montoya CL, Gonzalez ML, Ospina FE, Tob\u00f3n GJ. A rare case of amyopathic juvenile dermatomyositis associated with psoriasis successfully treated with ustekinumab. J Clin Rheumatol. 2017;23:129\u201330. https:\/\/doi.org\/10.1097\/RHU.0000000000000430.","journal-title":"J Clin Rheumatol"},{"key":"454_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/1346-8138.13265","volume":"43","author":"M Akiyama","year":"2016","unstructured":"Akiyama M, Ueno T, Kanzaki A, Kuwana M, Nagao M, Saeki H. Association of psoriasis with Hashimoto\u2019s thyroiditis, Sj\u00f6gren\u2019s syndrome and dermatomyositis. J Dermatol. 2016;43:711\u20132. https:\/\/doi.org\/10.1111\/1346-8138.13265.","journal-title":"J Dermatol"},{"key":"454_CR16","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/j.jaad.2013.11.012","volume":"70","author":"D Dicaro","year":"2014","unstructured":"Dicaro D, Bowen C, Dalton SR. Dermatomyositis associated with anti-tumor necrosis factor therapy in a patient with psoriasis. J Am Acad Dermatol. 2014;70:e64\u201365. https:\/\/doi.org\/10.1016\/j.jaad.2013.11.012.","journal-title":"J Am Acad Dermatol"},{"key":"454_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/archdermatol.2011.49","volume":"147","author":"NN Kim","year":"2011","unstructured":"Kim NN, Lio PA, Morgan GA, Jarvis JN, Pachman LM. Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis. Arch Dermatol. 2011;147:831\u20135. https:\/\/doi.org\/10.1001\/archdermatol.2011.49.","journal-title":"Arch Dermatol"},{"key":"454_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1590\/s1516-31802010000500012","volume":"128","author":"NP Machado","year":"2010","unstructured":"Machado NP, Camargo CZ, Oliveira AC, Buosi AL, Pucinelli ML, Souza AW. Association of anti-glomerular basement membrane antibody disease with dermatomyositis and psoriasis: case report. Sao Paulo Med J. 2010;128:306\u20138. https:\/\/doi.org\/10.1590\/s1516-31802010000500012.","journal-title":"Sao Paulo Med J"},{"key":"454_CR19","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.4045\/tidsskr.09.0184","volume":"129","author":"JT Gran","year":"2009","unstructured":"Gran JT, Gunnarsson R, M\u00f8rk NJ. En Mann med Erytrodermi, Muskelsvakhet Og vekttap [A man with erythrodermia, muscle weakness and weight loss]. Tidsskr nor Laegeforen. 2009;129:2240\u20131. https:\/\/doi.org\/10.4045\/tidsskr.09.0184.","journal-title":"Tidsskr nor Laegeforen"},{"key":"454_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2298\/vsp0405557","volume":"61","author":"MD Pavlovi\u0107","year":"2004","unstructured":"Pavlovi\u0107 MD, Zecevi\u0107 RD, Zolotarevski L. Psoriasis in a patient with dermatomyositis. Vojnosanit Pregl. 2004;61:557\u20139. https:\/\/doi.org\/10.2298\/vsp0405557.","journal-title":"Vojnosanit Pregl"},{"key":"454_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter J. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344\u20137. https:\/\/doi.org\/10.1056\/NEJM197502202920807.","journal-title":"N Engl J Med"},{"key":"454_CR22","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, Visser M, International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland), et al. 2017 European league against rheumatism\/american college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"454_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","volume":"54","author":"P Gerami","year":"2006","unstructured":"Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54(4):597\u2013613. Epub 2006 Jan 23. PMID: 16546580.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"454_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","volume":"68","author":"MG Cruellas","year":"2013","unstructured":"Cruellas MG, Viana Vdos S, Levy-Neto M, Souza FH, Shinjo SK. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clin (Sao Paulo). 2013;68(7):909\u201314. https:\/\/doi.org\/10.6061\/clinics\/2013(07)04. PMID: 23917652; PMCID: PMC3715024.","journal-title":"Clin (Sao Paulo)"},{"key":"454_CR25","doi-asserted-by":"publisher","unstructured":"Baer AN. Differential diagnosis of idiopathic inflammatory myopathies. Curr Rheumatol Rep. 2006;8:178\u2013187. https:\/\/doi.org\/10.1007\/s11926-996-0023-5. PMID: 16901075.","DOI":"10.1007\/s11926-996-0023-5"},{"key":"454_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.reuma.2016.10.010","volume":"14","author":"I Cabezas-Rodr\u00edguez","year":"2018","unstructured":"Cabezas-Rodr\u00edguez I, Morante-Bolado I, Brandy-Garc\u00eda A, Queiro-Silva R, Mozo L, Ballina-Garc\u00eda FJ. Anti-MDA5 dermatomyositis mimicking psoriatic arthritis. Reumatol Clin (Engl Ed). 2018;14:224\u20136. https:\/\/doi.org\/10.1016\/j.reuma.2016.10.010. English, Spanish.","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"454_CR27","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10067-009-1244-6","volume":"28","author":"M Haroon","year":"2009","unstructured":"Haroon M, Devlin J. Gottrons\u2019s papule in amyopathic dermatomyositis mimicking psoriasis. Clin Rheumatol. 2009;28:1245\u20136. https:\/\/doi.org\/10.1007\/s10067-009-1244-6.","journal-title":"Clin Rheumatol"},{"key":"454_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jhm.210","volume":"2","author":"LH Williams","year":"2007","unstructured":"Williams LH, Raugi GJ, Dhaliwal G, Saint S, Lipsky BA. Are we there yet? J Hosp Med. 2007;2:181\u20138. https:\/\/doi.org\/10.1002\/jhm.210.","journal-title":"J Hosp Med"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00454-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00454-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00454-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T13:37:24Z","timestamp":1746625044000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00454-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00454-7","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee (CAAE 78058424.8.0000.0068).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}